Neoantigens-normally absent from the human genome-that are presented by the major histocompatibility complex (MHC) on the surface of tumor cells can elicit T cell immune responses, which facilitates rejection of the tumor cells by the immune system [19]. This evidence concerns the gene HLA-C and neoplasm.